| 1 |
[GO] |
2025―Jun―14 |
Development of an inhalable dry powder formulation for inhibition of SARS-CoV-2 |
Justin Stella, Anja Germann, Oliver Janka, Sylvia Wagner, Marc Schneider |
| 2 |
[GO] |
2024―Jan―06 |
Effect of treatment with original or biosimilar adalimumab on SARS-CoV2 vaccination antibody titers |
Eva Dokoupilová, David Vetchý, Sylvie Pavloková, Markéta Hanuštiaková |